EMV vs TRP

ASX Healthcare sector comparison — updated 26 Mar 2026 — Healthcare sector

EMV

EMVISION FPO [EMV]

47LOW

TRP

TISSUE REP FPO [TRP]

47LOW

Score Breakdown

EMV TRP
Technical
44
75
Catalyst
55
50
Sentiment
50
50
Fundamental
70
54
Momentum
51
52
Risk Gate
50
42

Key Metrics

EMV Metric TRP
$144.1MMarket Cap$9.1M
44KAvg Volume (20d)41K
N/AShort InterestN/A
$2.43052-Week High$0.480
$1.49052-Week Low$0.150
-1.9%Daily Change+1.6%
$1.550Entry Price$0.155
-58.0%ROE-28.1%
-188.0%Profit Margin-113.9%

Active Signals

EMV Signals

●RSI drifting toward oversold territory — worth watching
●Trading below both moving averages — the trend is working against this one
●Below the 200-day average — the long-term trend is still working against it
●Adequate cash runway (8 quarters)
●Moderate revenue growth (+11%)
●EPS estimates revised upward (+6pts)
●Near 52-week low (6% of range)
●Deeply negative margins (-188%)

TRP Signals

●RSI drifting toward oversold territory — worth watching
●MACD momentum is picking up steam
●Stochastic just turned bullish from a low level — early reversal sign
●Trading below both moving averages — the trend is working against this one
●Volume surging at 2.2x normal while price climbs — real buying conviction behind this move
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Below the 200-day average — the long-term trend is still working against it
●Adequate cash runway (6 quarters)

Ask Scout AI to compare EMV and TRP in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
EMV Full Analysis → TRP Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).